BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 33240258)

  • 1. Circulating Neutrophil Extracellular Traps Signature for Identifying Organ Involvement and Response to Glucocorticoid in Adult-Onset Still's Disease: A Machine Learning Study.
    Jia J; Wang M; Ma Y; Teng J; Shi H; Liu H; Sun Y; Su Y; Meng J; Chi H; Chen X; Cheng X; Ye J; Liu T; Wang Z; Wan L; Zhou Z; Wang F; Yang C; Hu Q
    Front Immunol; 2020; 11():563335. PubMed ID: 33240258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease.
    Hu Q; Shi H; Zeng T; Liu H; Su Y; Cheng X; Ye J; Yin Y; Liu M; Zheng H; Wu X; Chi H; Zhou Z; Jia J; Sun Y; Teng J; Yang C
    Arthritis Res Ther; 2019 Jan; 21(1):9. PubMed ID: 30616678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
    Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
    Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil Extracellular Traps May Contribute to the Pathogenesis in Adult-onset Still Disease.
    Ahn MH; Han JH; Chwae YJ; Jung JY; Suh CH; Kwon JE; Kim HA
    J Rheumatol; 2019 Dec; 46(12):1560-1569. PubMed ID: 31043551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.
    Jia J; Wang M; Ma Y; Meng J; Zhu D; Chen X; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Liu T; Zhou Z; Wang F; Chen L; Yi D; Xiao Y; Yang C; Teng J; Hu Q
    BMC Med; 2023 Dec; 21(1):507. PubMed ID: 38124139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the Leukocyte Immunoglobulin-like Receptor A3 Gene With Neutrophil Activation and Disease Susceptibility in Adult-Onset Still's Disease.
    Wang M; Liu M; Jia J; Shi H; Teng J; Liu H; Sun Y; Cheng X; Ye J; Su Y; Chi H; Liu T; Wang Z; Wan L; Meng J; Ma Y; Yang C; Hu Q
    Arthritis Rheumatol; 2021 Jun; 73(6):1033-1043. PubMed ID: 33381895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult-onset Still's disease.
    Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
    Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.
    Zhu D; Chen L; Meng J; Wang M; Ma Y; Chen X; Xiao Y; Yi D; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Zhou Z; Yang C; Teng J; Jia J; Hu Q
    J Autoimmun; 2024 Apr; 144():103182. PubMed ID: 38460457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced type I interferon signature induces neutrophil extracellular traps enriched in mitochondrial DNA in adult-onset Still's disease.
    Ma Y; Wang M; Jia J; Meng J; Teng J; Zhu D; Shi H; Sun Y; Su Y; Liu H; Cheng X; Ye J; Chi H; Liu T; Chen X; Wan L; Zhou Z; Wang F; He D; Yang C; Hu Q
    J Autoimmun; 2022 Feb; 127():102793. PubMed ID: 35123211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still's disease: A prospective cohort study.
    Zhang W; Yang T; Zhang H; Xu Y; Yang Q; Liu Q; Gao Y; Wu J; Shao L; Zhang W
    Cytokine; 2021 Oct; 146():155642. PubMed ID: 34325118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-derived lipocalin-2 in adult-onset Still's disease: a novel biomarker of disease activity and liver damage.
    Jia J; Yang L; Cao Z; Wang M; Ma Y; Ma X; Liu Q; Teng J; Shi H; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Liu T; Wang Z; Wan L; Yang C; Hu Q
    Rheumatology (Oxford); 2021 Jan; 60(1):304-315. PubMed ID: 32766690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis.
    Seo JY; Suh CH; Jung JY; Kim AR; Yang JW; Kim HA
    Medicine (Baltimore); 2017 Jul; 96(29):e7546. PubMed ID: 28723775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
    Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
    Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still's Disease From Sepsis.
    Tian R; Chen X; Yang C; Teng J; Qu H; Liu HL
    Front Immunol; 2021; 12():654811. PubMed ID: 33868298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
    Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
    Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Mac-2 binding protein glycosylation isomer and galectin-3 levels in adult-onset Still's disease and their association with cytokines.
    Yoshida S; Koga T; Fujita Y; Yatsuhashi H; Matsumoto H; Sumichika Y; Saito K; Sato S; Asano T; Kobayakawa M; Ohira H; Mizokami M; Sugiyama M; Migita K
    Front Immunol; 2024; 15():1385654. PubMed ID: 38711500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
    Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
    BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients.
    Bodard Q; Langlois V; Guilpain P; Le Quellec A; Vittecoq O; Noel D; Eble V; Josse S; Schmidt J; Aouba A; Levesque H; Le Besnerais M; Benhamou Y
    J Autoimmun; 2021 Jan; 116():102541. PubMed ID: 32943282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.